## Abstract Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor cells, it shows the existence of freeโcirculating tumorโassociated DNA. The objective of our study w
Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients
โ Scribed by Kenji Hibi; Hiroshi Nakayama; Taiji Yamazaki; Tsunenobu Takase; Masumi Taguchi; Yasushi Kasai; Katsuki Ito; Seiji Akiyama; Akimasa Nakao
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 85 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1480
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract We previously proved that p16 promoter methylation present in the tumors of colorectal cancer patients can be detected in the serum of those same patients using methylationโspecific PCR (MSP). To seek the possibility that this technique could be applied to the monitoring of cancer recur
In most cases the analysis of DNA mutations in presence of a high excess of wild type DNA fail because of the low sensitivity of the performed method for mutation detection. Here we describe the new high-sensitive and non-radioactive HD-PCR method (for HeteroDuplex-PCR). In opposite to the conventio
## Abstract Abnormal DNA methylation is a feature of most types of cancer, which is reflected in cellโfree circulating DNA in plasma. It is, however, unknown whether surgical removal of the tumor and subsequent therapy induces changes in plasma DNA methylation, which can be used to monitor treatmen